
|Articles|July 1, 2004
AMO to work with Quest Vision on presbyopic IOLs
Santa Ana, CA-Advanced Medical Optics Inc. (AMO) has forged a 1-year research and evaluation licensing agreement with Quest Vision Technologies Inc. to develop accommodating IOL designs. Under the agreement, which was announced May 3, AMO will own a minority interest in Quest Vision, with an option to buy the company after 1 year.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
AAO 2025: Which lens to consider in patients with pseudoexfoliation
3
AAO 2025: The evolution of eye care on display at AAO 2025
4
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
5